Mark van der Laan, PhD, and Toru Shirakawa, MD, receive $1 million to Improve Comparative Clinical Effectiveness Research

Congratulations to CPH AGG member, Mark van der Laan, PhD, CPH PhD student, Toru Shirakawa, MD, and co-investigators from the Kaiser Permanente Division of Research (DOR) for receiving funding from the Patient-Centered Outcomes Research Institute (PCORI) to improve how researchers compare the clinical effectiveness of sequential treatment decisions.